Document ID: chunk:federal_register_of_legislation:F2018L01177:reg:9:p2
Version: federal_register_of_legislation:F2018L01177
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6377–9464

the inflammation, oedema, ulceration or haemorrhage of the nasal mucosa.
(9)          for sinusitis affecting the maxillary sinus only, having a specified dental condition affecting the tissues adjacent to the affected maxillary sinus at the time of the clinical onset of sinusitis;
Note: specified dental condition is defined in the Schedule 1 - Dictionary.
(10)      having impaired drainage of the sinus at the time of the clinical worsening of sinusitis;
Note: impaired drainage of the sinus is defined in the Schedule 1 - Dictionary.
(11)      having a viral, bacterial or fungal respiratory tract infection at the time of the clinical worsening of sinusitis;
(12)      being in an immunocompromised state as specified at the time of the clinical worsening of sinusitis;
Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.
(13)      having a specified medical condition at the time of the clinical worsening of sinusitis;
Note: specified medical condition is defined in the Schedule 1 - Dictionary.
(14)      undergoing a course of therapeutic radiation for cancer, where the nasal cavity and paranasal sinuses were in the field of radiation, before the clinical worsening of sinusitis;
(15)      smoking at least one pack-year of cigarettes, or the equivalent thereof in other tobacco products, before the clinical worsening of sinusitis, and:
(a)          smoking commenced at least one year before the clinical worsening of sinusitis; and
(b)          where smoking has ceased, the clinical worsening of sinusitis has occurred within three months of smoking cessation;
            Note: pack-year of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(16)       being exposed to second-hand smoke:
(a)          for at least 1 000 hours before the clinical worsening of sinusitis; and
(b)          where the first exposure to second-hand smoke commenced at least one year before the clinical worsening of sinusitis; and
(c)          where the last exposure to second-hand smoke occurred within the three months before the clinical worsening of sinusitis;
Note: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.
(17)      inhaling a drug or irritant substance which results in:
(a)           acute nasal symptoms or signs within 48 hours of the inhalation; and
(b)          scarring or erosion of the nasal or sinus mucosa;
before the clinical worsening of sinusitis;
Note 1: Examples of drugs include cocaine, lidocaine, methylphenidate and narcotics.

            Note 2: Examples of irritant substances include gases (ammonia, chlorine, mustard, nitrogen dioxide, sulphur dioxide), powdered solids (aspirin, baking soda, levamisole, capsules, tablets, pills) and lewisite.

            Note 3: Examples of acute nasal symptoms or signs include rhinorrhoea, and the inflammation, oedema, ulceration or haemorrhage of the nasal mucosa.
(18)      for sinusitis affecting the maxillary sinus only, having a specified dental condition affecting the tissues adjacent